Advertisement

Topics

Search Results for "Tingkatan Satu Sejarah Nota"

07:10 EDT 19th August 2017 | BioPortfolio

Matching Channels

None

Matching News

Gut microbe may improve fatty liver

Oral administration of a commensal gut microbe, Faecalibacterium prausnitzii, improves fatty liver in mice. F. prausnitzii is considered one of the most important bacterial indicators of a healthy gut...

Cancer focused ValiRx inks licensing agreement with Bangladeshi group Mystic Pharmaceuticals

Cancer-focused biotech ValiRx Plc (LON:VAL) has inked what it hopes will be the first of many licensing agreements for its products. The deal is with Bangladeshi group Mystic Pharmaceuticals Limited...

Cancer-focused ValiRx inks licensing agreement with Bangladeshi group Mystic Pharmaceuticals

Cancer-focused biotech ValiRx Plc (LON:VAL) has inked what it hopes will be the first of many licensing agreements for its products. The deal is with Bangladeshi group Mystic Pharmaceuticals Limited...

ValiRx recruits three experienced industry figures to advisory board

ValiRx Plc (LON:VAL), the cancer drug developer, has recruited three people to its advisory board whose job it is to provide “strategic guidance and technical advice” to the firm’s main board of...

Cycle Pharmaceuticals Receives FDA Approval of NityrTM (nitisinone) Tablets for Treatment of HT-1

NityrTM is the first formulation of nitisinone treatment for HT-1 that does not require refrigeration NityrTM can be disintegrated in w...

U.S. FDA Accepts for Review the Application of Ibrutinib (IMBRUVICA®) for Chronic Graft-Versus-Host-Disease (cGVHD) After Failure of One or More Lines of Systemic Therapy

RARITAN, N.J., April 4, 2017 /PRNewswire/ -- Janssen Research & Development, LLC announced today the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Ap...

U.S. FDA Approves IMBRUVICA® (ibrutinib) as First and Only Approved Treatment for Adult Patients with Chronic Graft-Versus-Host-Disease (cGVHD) After Failure of One or More Lines of Systemic Therapy

HORSHAM, Pa., Aug. 2, 2017 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of adult patients with chronic graft-versus-host-disease (...

Matching PubMed Articles

DFT Study on the Complexation of NOTA as a Bifunctional Chelator with Radiometal Ions.

1,4,7 triazacyclononane-1,4,7 triacetic acid (NOTA) is a key bifunctional chelator utilized for the complexation of metal ions in radiopharmaceutical applications; the ability of these chelators depen...

Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of (64) CuCu/NOTA peptide-based GRPR antagonists.

In this study we investigated for the first time the influence of 2-aminoethyl-piperazine-1-carboxylic acid (APCA) and amino-hexanedioic-1-acid (AHDA) on tumor uptake and elimination kinetics of [(64)...

Ficusnotins A-F: Rare diarylbutanoids from the leaves of Ficus nota.

Six diarylbutanoids, designated as ficusnotins A-F, with a rare carbon skeleton consisting of two aromatic rings separated by an unbranched C4-chain have been isolated from the leaves of Ficus nota (B...

The Non Operative Treatment for Acute Appendicitis (NOTA) Study: Is Less Surgery Better Surgery?

Path of infectious diseases in Brazil in the last 50 years: an ongoing challenge.

In this article, we comment on the main features of infectious diseases in Brazil in the last 50 years, highlighting how much of this path Revista de Saúde Pública could portray. From 1967 to 2016, ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement